Abstract
BackgroundThalidomide has been gradually recognized in the treatment of IBD because of its anti-angiogenesis and immunomodulatory effect. The safety and adverse reactions of thalidomide have also attracted considerable attention. This...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
